MarkWide Research

Sale!

Anticoccidial Drugs Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: December, 2022
No of Pages: 164
Delivery Format: PDF+ Excel

$2,950.00

During the forecast period, the worldwide market for anticoccidial medicines is expected to increase at a CAGR of 5.8%. (2019-2024). Coccidiosis is a parasite disease that affects the intestinal system of animals, causing severe diarrhoea. Anticoccidial medications are used to prevent and treat it.

The expanding demand for meat and poultry products, as well as increased knowledge of animal health, are driving the demand for anticoccidial medications. However, the availability of alternative treatments and tight anticoccidial drug use laws are projected to limit market growth.

During the forecast period, the poultry segment is expected to develop at the fastest CAGR.

The global market for anticoccidial medicines is divided into three sections: animal type, drug type, and geography.

The market is divided into poultry, ruminants, swine, and other animal types.

The market is divided into three types of drugs: ionophores, coccidiostats, and others.

The market is divided into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.

Merck & Co., Inc. (US), Boehringer Ingelheim International GmbH (Germany), Zoetis (US), Elanco (US), Virbac (France), Ceva Sante Animale (France), and Bayer AG (Germany) are among the market’s prominent players.

2. Market Size and Growth of Anticoccidial Drugs
Anticoccidial medications are used to prevent or cure coccidiosis, a parasite disease that affects animals’ intestines. Anticoccidial medicines are classified into two types: ionophores and coccidiostats.

Ionophores are antibiotics that kill or inhibit the growth of the parasites that cause coccidiosis. They are usually administered to animals as a prophylactic strategy before they are exposed to parasites.

Coccidiostats are medications that inhibit parasite growth but do not kill them. They are commonly used to treat animals that have already been infected with coccidiosis.

From 2019 to 2024, the global market for anticoccidial medicines is predicted to increase at a 5.5% CAGR. Growing demand for meat and poultry products, as well as increased knowledge of animal health and welfare, are driving the market.

The ionophores section of the anticoccidial medicine market is predicted to be the largest and fastest-growing. This is related to the increasing usage of ionophores as a coccidiosis prophylactic strategy.

The North American market for anticoccidial medications is predicted to be the largest and fastest-growing. This is due to the region’s enormous population of livestock animals as well as increased awareness of animal health and welfare.

Due to rising demand for meat and poultry products in the region, the Asia-Pacific market is predicted to develop at the fastest CAGR during the forecast period.

Zoetis, Merck, Elanco, Bayer, and Boehringer Ingelheim are some of the major companies in the anticoccidial medicine market.

3. Market Segmentation of Anticoccidial Drugs
The global anticoccidial medicines market is divided into drug type, illness type, and distribution channel segments.

The global market for anticoccidial medicines is divided into three categories: ionophores, coccidiostats, and vaccines. The global market for anticoccidial medicines is divided into three categories: poultry, cattle, and companion animals. The global market for anticoccidial medicines is divided into three segments based on distribution channel: veterinary hospitals, veterinary clinics, and online retailers.

During the projected period, the ionophores segment is expected to increase at the fastest CAGR. Ionophores are further subdivided into monensin, lasalocid, narasin, and salinomycin. Monensin is the most extensively used ionophore in poultry for the prevention and treatment of coccidiosis. Lasalocid is used in sheep and cattle to prevent and cure coccidiosis. Narasin is a medication used to prevent and cure coccidiosis in chickens. Salinomycin is used in chickens to prevent coccidiosis.

During the projected period, the coccidiostats sector is expected to increase at the second-fastest CAGR. Coccidiostats are further subdivided into diclazuril, toltrazuril, and robenidine. Diclazuril is used in chickens to prevent coccidiosis. Toltrazuril is used to prevent and cure coccidiosis in poultry. Robenidine is used in chickens to prevent coccidiosis.

During the projected period, the vaccines segment is expected to increase at the third-fastest CAGR. Vaccines are further subdivided into live attenuated vaccinations and inactivated vaccinations. Eimeria tenella, Eimeria acervulina, Eimeria maxima, Eimeria brunetti, Eimeria necatrix, and others are all sub-segments of the live attenuated vaccine segment. The segment of inactivated vaccines

4. Market Drivers for Anticoccidial Drugs
The market for anticoccidial medications is expanding fast as the prevalence of coccidiosis increases and public knowledge of the condition grows. A protozoal infection causes the disease, which is one of the primary causes of death in chickens. The sickness is extremely contagious and can swiftly spread across a flock of birds. Coccidiosis has a mortality rate of up to 80%.

The only way to avoid the sickness and protect chickens from its deadly effects is to use anticoccidial medications. As the poultry industry expands, the market for anticoccidial medications is likely to rise dramatically in the next few years.

The rising prevalence of coccidiosis and expanding public knowledge of the disease are the primary drivers of the anticoccidial medicine industry. The disease is endemic in many parts of the world, and the number of cases is rising due to extensive chicken production. The increased public knowledge of the disease and its possible implications is also propelling the anticoccidial medicine industry.

Other market factors include rising demand for chicken products and an increase in the number of poultry farms. The poultry industry is quickly expanding due to rising demand for chicken and other poultry products. Because of the increased demand for chicken and other poultry products, the number of poultry farms is likewise growing.

The biggest restrictions on the market for anticoccidial medications are the high cost of the drugs and the disease’s lack of awareness. The disease is not widely known, and the vast majority of people are unaware of its presence. The disease’s lack of awareness is a key impediment to the expansion of the anticoccidial medicine market.

Because of the increasing prevalence of coccidiosis and expanding public knowledge of the condition, the market for anticoccidial medications is enormous. As the poultry business expands, the market is likely to develop significantly in the next few years.

5. Difficulties in the Market for Anticoccidial Drugs
The anticoccidial medicine market has several problems, including the following:

1. The high price of anticoccidial medications

2. The requirement for anticoccidial medicine dosing on a regular basis

3. The possibility of anticoccidial antibiotic resistance developing

4. The lack of licenced vaccinations for coccidial prophylaxis.

5. The absence of adequate coccidiosis control strategies

Trends in the Anticoccidial Drug Market
During the forecast period, the worldwide market for anticoccidial medicines is expected to increase at a CAGR of 6.3%. (2019-2024). The increased frequency of poultry diseases and rising demand for chicken meat and eggs are the primary factors driving the growth of this industry.

Pathogens such as bacteria, viruses, and parasites cause poultry illnesses. Because of increased mortality and decreased production, these illnesses can cause significant economic losses in the poultry business. Anticoccidial medications are used to prevent and treat certain illnesses.

Another key factor driving the expansion of the anticoccidial medicine market is rising demand for chicken meat and eggs. Poultry meat is a high-protein food that is popular among customers due to its low fat content. Eggs are high in minerals like vitamin A, vitamin B12, and iron. They are also high in protein and choline. Consumers’ increased health concerns are driving up demand for poultry products.

The increasing incidence of drug-resistant pathogen strains poses a significant obstacle to the expansion of the anticoccidial medicine market. Drug-resistant bacteria are resistant to drug action and can cause major health concerns. These strains have the potential to spread swiftly and trigger large-scale disease outbreaks.

Zoetis, Merck, Elanco, Boehringer Ingelheim, and Bayer are the key participants in the global anticoccidial medicines market.

The increased prevalence of poultry diseases, as well as the increasing demand for poultry meat and eggs, are the primary reasons driving the global anticoccidial medicines market. The increasing incidence of drug-resistant pathogen strains poses a significant impediment to the market’s expansion.

Forecast for the Anticoccidial Drugs Market
The global market for anticoccidial medicines is expected to increase at a CAGR of roughly 5% between 2019 and 2024. The expanding demand for chicken meat and products, as well as increased awareness about animal health, are the primary drivers of this market.

Poultry meat is an important source of protein for humans and is widely consumed around the world. People’s changing dietary habits and an expanding population are driving up demand for poultry meat.People’s disposable incomes are increasing, as is their health consciousness, which is fueling demand for poultry meat.

Another factor driving the growth of the anticoccidial medicine market is the rise in the prevalence of zoonotic infections. Zoonotic illnesses are those that can be passed from one animal to another. Bacteria, viruses, and parasites can all cause these disorders. Avian influenza, salmonellosis, and campylobacteriosis are examples of prevalent zoonotic infections.

The increased awareness of animal health is also propelling the anticoccidial medicine market forward. Animals are frequently afflicted with diseases that might result in death. Anticoccidial medications are used to both prevent and treat these infections.

The rising limits on the use of anticoccidial medications are a significant problem for market participants. Various governmental and non-governmental entities implement these regulations. They are intended to safeguard customers from the negative consequences of these medications.

Zoetis, Merck, Elanco, Bayer, and Boehringer Ingelheim are some of the leading companies in the global anticoccidial medicine market.

 DETAILS
 

By Drug Class

 

 

    • Ionophores

 

    • Antibiotic

 

    • Sulphonamides

 

    • Amprolium

 

    • Others

 

 

 

By Animal Type

 

 

    • Livestock
        • Cattle

       

        • Poultry

       

        • Others

       

    • Companion Animal
 

By Distribution Channel

 

 

    • Veterinary Hospitals

 

    • Retail Pharmacy

 

    • Online Pharmacy

 

Zoetis, Bayer AG, Novartis AG, Virbac S.A, HIPRA, Elanco, Boehringer Ingelheim International GmbH, Virbac.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF